COMPANY

Radionetics Oncology

HQ: San Diego, CA source · radionetics.com ↗

Radionetics Oncology is a clinical-stage San Diego, CA radiopharmaceutical company, spun out of Crinetics in 2021, developing small-molecule GPCR-targeted radiopharmaceuticals for solid tumors. A 2024 agreement gave Lilly an exclusive option to acquire it for $1 billion. From company website Source · Oct 12, 2026

Keywords: radiopharmaceuticals oncology small molecule GPCR clinical-stage spinout San Diego, CA

Location: San Diego, CA · source · Oct 13, 2026

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Series A · $52.5M · announced Jan 3, 2024 Company release ↗
Source quote
- Jan 3, 2024 · Company release ↗
  “Radionetics Oncology Raises $52.5 Million Series A to Advance First-in-Class Radiopharmaceutical Pipeline and Announces the Appointment of Industry Leader”

Raises announced in these releases: $52.5M disclosed.

From the company’s own releases; this list is partial. All raises and deals